Source: Eur Respir J 2008; 32: 783-795
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Griese M., Kappler M., Gaggar A., Hartl D.. Inhibition of airway proteases in cystic fibrosis lung disease. Eur Respir J 2008; 32: 783-795

Member's Comments

No comment yet.

Related content which might interest you: The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis Source: Eur Respir J 2015; 46: 384-394 Year: 2015 Neutrophil elastase and lung damage in cystic fibrosis Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Inhaled heparin in cystic fibrosis Source: Eur Respir J 2006; 27: 354-358 Year: 2006 Small airways disease in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=21 Year: 2006 Targeting of cathepsin S reduces cystic fibrosis-like lung disease Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018 Year: 2019 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 354-360 Year: 2009 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Arginase in patients with cystic fibrosis airway disease Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 Interstitial fibrosis with a nodule Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session Year: 2007